Inhibition of α-glucosidase activity by curcumin loaded on ZnO@rGO nanocarrier for potential treatment of diabetes mellitus
dc.contributor.author | Liu, L. | |
dc.contributor.author | Wang, Z. | |
dc.contributor.author | Yap, P.L. | |
dc.contributor.author | Zhang, Q. | |
dc.contributor.author | Ni, Y. | |
dc.contributor.author | Losic, D. | |
dc.date.issued | 2024 | |
dc.description.abstract | Curcumin (Cur) is an acidic polyphenol with some effects on α-glucosidase (α-Glu), but Cur has disadvantages such as being a weak target, lacking passing the blood-brain barrier and having low bioavailability. To enhance the curative effect of Cur, the hybrid composed of ZnO nanoparticles decorated on rGO was used to load Cur (ZnO@rGO-Cur). The use of the multispectral method and enzyme inhibition kinetics analysis certify the inhibitory effect and interaction mechanism of ZnO@rGO-Cur with α-Glu. The static quenching of α-Glu with both Cur and ZnO@rGO-Cur is primarily driven by hydrogen bond and van der Waals interactions. The conformation-changing ability by binding to the neighbouring phenolic hydroxyl group of Cur increased their ability to alter the secondary structure of α-Glu, resulting in the inhibition of enzyme activity. The inhibition constant (Ki, Cur > Kis,ZnO@rGO-Cur ) showed that the inhibition effect of ZnO@rGO-Cur on α-Glu was larger than that of Cur. The CCK-8 experiments proved that ZnO@rGO nanocomposites have good biocompatibility. These results suggest that the therapeutic potential of ZnO@rGO-Cur composite is an emerging nanocarrier platform for drug delivery systems for the potential treatment of diabetes mellitus. | |
dc.description.statementofresponsibility | Linghong Liu, Zhu Wang, Pei Lay Yap, Qiulan Zhang, Yongnian Ni, Dusan Losic | |
dc.identifier.citation | Luminescence, 2024; 39(1):e4668-1-e4668-12 | |
dc.identifier.doi | 10.1002/bio.4668 | |
dc.identifier.issn | 1522-7235 | |
dc.identifier.issn | 1522-7243 | |
dc.identifier.orcid | Yap, P.L. [0000-0001-7346-8139] | |
dc.identifier.orcid | Losic, D. [0000-0002-1930-072X] | |
dc.identifier.uri | https://hdl.handle.net/2440/143561 | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.grant | 21665017 | |
dc.rights | © 2024 John Wiley & Sons Ltd. | |
dc.source.uri | http://dx.doi.org/10.1002/bio.4668 | |
dc.subject | curcumin; graphene; inhibition; molecule interaction; ZnO@rGO; α-glucosidase | |
dc.subject.mesh | alpha-Glucosidases | |
dc.subject.mesh | Curcumin | |
dc.subject.mesh | Diabetes Mellitus | |
dc.subject.mesh | Drug Delivery Systems | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Nanoparticles | |
dc.subject.mesh | Zinc Oxide | |
dc.subject.mesh | Glycoside Hydrolase Inhibitors | |
dc.title | Inhibition of α-glucosidase activity by curcumin loaded on ZnO@rGO nanocarrier for potential treatment of diabetes mellitus | |
dc.type | Journal article | |
pubs.publication-status | Published |